Home  /  Resource Library  /  R-CHOP Versus R-Bendamustine with or without Rituximab Maintenance in Newly Diagnosed Follicular Lymphoma Patients with High SUV at Baseline PET

R-CHOP Versus R-Bendamustine with or without Rituximab Maintenance in Newly Diagnosed Follicular Lymphoma Patients with High SUV at Baseline PET

ASH 2020: Results of a study comparing different chemoimmunotherapy regimens for first line treatment of follicular lymphoma.